Virus injected into tumors shows promise in early cancer trial
NCT ID NCT06311578
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times
Summary
This early-stage study tests a new treatment called JNJ-87704916, a virus designed to infect and kill cancer cells. It is injected directly into tumors, either alone or with another drug (cetrelimab), for people with advanced solid tumors that have not responded to standard therapies. The main goals are to check safety, find the best dose, and see if it shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de l'Universite de Montreal
RECRUITINGMontreal, Quebec, H2X 0A9, Canada
-
Fox Chase Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
-
Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
Hosp Univ Fund Jimenez Diaz
RECRUITINGMadrid, 28040, Spain
-
Hosp Univ Hm Sanchinarro
RECRUITINGMadrid, 28050, Spain
-
Hosp Univ Vall D Hebron
RECRUITINGBarcelona, 08035, Spain
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
-
Toronto General Hospital
RECRUITINGToronto, Ontario, M5G 2C4, Canada
-
UPMC Cancer Centers
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
Conditions
Explore the condition pages connected to this study.